Form 4 for NVAX NOVAVAX INC
Accepted 2021-07-06 00:00:00 ET · period of report 2021-07-01 · accession 0001209191-21-045561 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-06 | 2021-07-01 | NVAX | YOUNG JAMES F | Dir | M - OptEx | — | +10.0K | 75.1K | +15% | — |
| D | 2021-07-06 | 2021-07-01 | NVAX | YOUNG JAMES F | Dir | M - OptEx | $0.00 | -10.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-01 | M | A | 10,000 | — | 75,090 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. |
| 2 | Derivative | Restricted Stock Units | 2021-07-01 | M | D | 10,000 | $0.00 | 0 | D | — · — to — | 10,000 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. (F3) Fifty percent (50%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on January 1, 2021 and the remaining fifty percent (50%) vested on July 1, 2021, in each case subject to continued service on the Company's Board of Directors through such vesting date. |